黄熱ワクチンの世界市場レポート 2025年

黄熱ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.1％で58億4,000万米ドルに成長します。予測期間の成長は、協力やパートナーシップの増加、定期的なワクチン接種スケジュールとの統合、サーベイランスとモニタリング、民間セクターの関与の増加、ワクチン追跡のためのデジタル技術の採用に起因しています。予測期間における主な動向としては、ワクチン形態の多様化、パンデミックへの備え、規制の変更、ヘルスケアインフラの改善、消費者教育・啓発などが挙げられます。

黄熱ワクチン市場は、海外渡航の増加に牽引されて成長する見込みです。国際旅行は、観光、ビジネス、または個人的な理由で国境を越えて個人が移動することを含み、世界の接続の強化、経済拡大、パンデミック後の旅行規制の緩和により増加傾向にあります。黄熱病が流行している地域を訪れる旅行者にとって、この黄熱ワクチンは、感染を防ぎ、国際的な健康ガイドラインを遵守するために極めて重要です。例えば、世界観光機関が2024年1月に発表したところによると、世界の国際観光客（宿泊客）は2023年に12億8,600万人に達し、2022年の9億6,000万人から大幅に増加しました。この急増は、黄熱ワクチンに対する需要の高まりを浮き彫りにしています。

黄熱ワクチン市場の主要企業は、世界のワクチン需要の高まりに対応するため、T細胞適応性ブースターワクチンなどの先進的な次世代ワクチンの開発に注力しています。T細胞順応性ブースター・ワクチンは、免疫系のメモリーT細胞反応を強化し、特定の病原体に対する免疫力を長期かつ強固なものにするよう設計されています。例えば、英国を拠点とするバイオテクノロジー企業Emergex Vaccines Holding Limitedは、2022年4月に米国を拠点とする非営利団体ATCCと提携し、黄熱病用に調整されたCD8+T細胞適応型ワクチンを発表しました。これらのワクチンは、ウイルス感染細胞を識別し排除するために重要な強力な細胞傷害性T細胞応答を刺激します。メモリーCD8+T細胞の産生を促進することで、これらのワクチンは細胞性免疫に焦点を当て、従来の抗体ベースのアプローチを補完することで、黄熱病に対する耐久性のある防御を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界黄熱ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の黄熱ワクチン市場：成長率分析
• 世界の黄熱ワクチン市場の実績：規模と成長, 2019-2024
• 世界の黄熱ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界黄熱ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の黄熱ワクチン市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉
• 液体
• 世界の黄熱ワクチン市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 疼痛管理薬
• 経口補水液
• 世界の黄熱ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定期予防接種
• 旅行者
• その他の用途
• 世界の黄熱ワクチン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• ポイントオブケアセンター
• その他のエンドユーザー
• 世界の黄熱ワクチン市場、粉末の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 再構成用凍結乾燥粉末
• 凍結乾燥粉末（再構成用）
• 世界の黄熱ワクチン市場、液体の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• すぐに使える液体ワクチン
• プレフィルドシリンジ入り液体ワクチン

第7章 地域別・国別分析

• 世界の黄熱ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の黄熱ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 黄熱ワクチン市場：競合情勢
• 黄熱ワクチン市場：企業プロファイル
  • Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• WuXi Biologics
• Novavax Inc.
• Beijing Tiantan Biological
• Bavarian Nordic A/S
• Valneva SE
• Biological E. Limited
• Bio-Manguinhos
• Instituto Butantan
• Bio Farma
• Panacea Biotec
• Biovac
• Institut Pasteur de Dakar
• Ology Bioservices
• Gavi
• Wuhan Institute of Biological Products

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 黄熱ワクチン市場2029：新たな機会を提供する国
• 黄熱ワクチン市場2029：新たな機会を提供するセグメント
• 黄熱ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The yellow fever vaccine is a live, attenuated viral vaccine used to prevent yellow fever, a serious viral infection transmitted by mosquitoes. It is typically administered as a single dose and provides long-lasting immunity, often lifelong. The vaccine is crucial for individuals residing in or traveling to areas where yellow fever is endemic.

The main presentations of the yellow fever vaccine include powder and liquid forms. Yellow fever vaccine powder is lyophilized (freeze-dried), requiring reconstitution with a specific diluent before administration to confer immunity against the yellow fever virus. This vaccine is utilized for routine immunization, travelers' vaccinations, and other applications, and is distributed through various channels including hospitals, diagnostic centers, and point-of-care facilities.

The yellow fever vaccine market research report is one of a series of new reports from The Business Research Company that provides yellow fever vaccine market statistics, including yellow fever vaccine industry global market size, regional shares, competitors with a yellow fever vaccine market share, detailed yellow fever vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the yellow fever vaccine industry. This yellow fever vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The yellow fever vaccine market size has grown strongly in recent years. It will grow from $4.54 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.

The yellow fever vaccine market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.

The yellow fever vaccine market is poised for growth driven by increasing international travel. International travel involves the movement of individuals across borders for tourism, business, or personal reasons and is on the rise due to enhanced global connectivity, economic expansion, and eased travel restrictions post-pandemic. The yellow fever vaccine is crucial for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health guidelines. For example, the World Tourism Organization reported in January 2024 that global international tourists (overnight visitors) reached 1.286 billion in 2023, marking a significant increase from 960 million in 2022. This surge highlights the growing demand for the yellow fever vaccine.

Leading companies in the yellow fever vaccine market are concentrating on developing advanced next-generation vaccines, such as the T-cell adaptive booster vaccine, to meet the rising global demand for vaccines. The T-cell adaptive booster vaccine is designed to enhance the immune system's memory T-cell response, ensuring prolonged and robust immunity against specific pathogens. For instance, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization, in April 2022 to introduce CD8+ T-cell adaptive vaccines tailored for yellow fever. These vaccines stimulate a potent cytotoxic T-cell response critical for identifying and eliminating virus-infected cells. By promoting memory CD8+ T-cell production, these vaccines provide durable protection against yellow fever by focusing on cellular immunity, complementing traditional antibody-based approaches.

In October 2022, Emergex Vaccines Holding Limited expanded its capabilities by acquiring the assets of Zosano Pharma Corporation, a US-based pharmaceutical company specializing in transdermal delivery systems. This acquisition strengthens Emergex Vaccines' vaccine delivery methods, enhancing its ability to develop and commercialize innovative vaccines, including those targeting yellow fever.

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

North America was the largest region in the yellow fever vaccine market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yellow fever vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The yellow fever vaccine market consists of sales of vaccine syringes, needles, and vaccine storage equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yellow Fever Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on yellow fever vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yellow fever vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yellow fever vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Powder; Liquid
• 2) By Treatment Type: Pain Management Drugs; Oral Rehydration
• 3) By Application: Routine Immunization; Travelers; Other Applications
• 4) By End-User: Hospitals; Diagnostic Centers; Point Of Care Centers; Other End Users
• Subsegments:
• 1) By Powder: Lyophilized Powder For Reconstitution; Freeze-Dried Powder For Reconstitution
• 2) By Liquid: Ready-To-Use Liquid Vaccine; Liquid Vaccine In Pre-Filled Syringes
• Companies Mentioned: Merck and Co Inc.; Sanofi S.A.; GSK plc; Takeda Pharmaceutical Company; Lonza Group Ag
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Yellow Fever Vaccine Market Characteristics

3. Yellow Fever Vaccine Market Trends And Strategies

4. Yellow Fever Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Yellow Fever Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Yellow Fever Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Yellow Fever Vaccine Market Growth Rate Analysis
• 5.4. Global Yellow Fever Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Yellow Fever Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Yellow Fever Vaccine Total Addressable Market (TAM)

6. Yellow Fever Vaccine Market Segmentation

• 6.1. Global Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powder
• Liquid
• 6.2. Global Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Management Drugs
• Oral Rehydration
• 6.3. Global Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Routine Immunization
• Travelers
• Other Applications
• 6.4. Global Yellow Fever Vaccine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Point Of Care Centers
• Other End Users
• 6.5. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lyophilized Powder For Reconstitution
• Freeze-Dried Powder For Reconstitution
• 6.6. Global Yellow Fever Vaccine Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ready-To-Use Liquid Vaccine
• Liquid Vaccine In Pre-Filled Syringes

7. Yellow Fever Vaccine Market Regional And Country Analysis

• 7.1. Global Yellow Fever Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Yellow Fever Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Yellow Fever Vaccine Market

• 8.1. Asia-Pacific Yellow Fever Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Yellow Fever Vaccine Market

• 9.1. China Yellow Fever Vaccine Market Overview
• 9.2. China Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Yellow Fever Vaccine Market

• 10.1. India Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Yellow Fever Vaccine Market

• 11.1. Japan Yellow Fever Vaccine Market Overview
• 11.2. Japan Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Yellow Fever Vaccine Market

• 12.1. Australia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Yellow Fever Vaccine Market

• 13.1. Indonesia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Yellow Fever Vaccine Market

• 14.1. South Korea Yellow Fever Vaccine Market Overview
• 14.2. South Korea Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Yellow Fever Vaccine Market

• 15.1. Western Europe Yellow Fever Vaccine Market Overview
• 15.2. Western Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Yellow Fever Vaccine Market

• 16.1. UK Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Yellow Fever Vaccine Market

• 17.1. Germany Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Yellow Fever Vaccine Market

• 18.1. France Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Yellow Fever Vaccine Market

• 19.1. Italy Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Yellow Fever Vaccine Market

• 20.1. Spain Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yellow Fever Vaccine Market

• 21.1. Eastern Europe Yellow Fever Vaccine Market Overview
• 21.2. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Yellow Fever Vaccine Market

• 22.1. Russia Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Yellow Fever Vaccine Market

• 23.1. North America Yellow Fever Vaccine Market Overview
• 23.2. North America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Yellow Fever Vaccine Market

• 24.1. USA Yellow Fever Vaccine Market Overview
• 24.2. USA Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Yellow Fever Vaccine Market

• 25.1. Canada Yellow Fever Vaccine Market Overview
• 25.2. Canada Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Yellow Fever Vaccine Market

• 26.1. South America Yellow Fever Vaccine Market Overview
• 26.2. South America Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Yellow Fever Vaccine Market

• 27.1. Brazil Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Yellow Fever Vaccine Market

• 28.1. Middle East Yellow Fever Vaccine Market Overview
• 28.2. Middle East Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Yellow Fever Vaccine Market

• 29.1. Africa Yellow Fever Vaccine Market Overview
• 29.2. Africa Yellow Fever Vaccine Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Yellow Fever Vaccine Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Yellow Fever Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Yellow Fever Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Yellow Fever Vaccine Market Competitive Landscape
• 30.2. Yellow Fever Vaccine Market Company Profiles
  • 30.2.1. Merck and Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis

31. Yellow Fever Vaccine Market Other Major And Innovative Companies

• 31.1. WuXi Biologics
• 31.2. Novavax Inc.
• 31.3. Beijing Tiantan Biological
• 31.4. Bavarian Nordic A/S
• 31.5. Valneva SE
• 31.6. Biological E. Limited
• 31.7. Bio-Manguinhos
• 31.8. Instituto Butantan
• 31.9. Bio Farma
• 31.10. Panacea Biotec
• 31.11. Biovac
• 31.12. Institut Pasteur de Dakar
• 31.13. Ology Bioservices
• 31.14. Gavi
• 31.15. Wuhan Institute of Biological Products

32. Global Yellow Fever Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Yellow Fever Vaccine Market

34. Recent Developments In The Yellow Fever Vaccine Market

35. Yellow Fever Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Yellow Fever Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Yellow Fever Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Yellow Fever Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer